Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | FNTA | P49354 | 2/20 | 0.34 |
| ▸ | FNTB | P49356 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22729651 | 1.00 | SMN1; SMN2 (0.35) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL22729725 | 0.92 | APP (0.37) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL22729837 | 0.86 | MGLL (0.38) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL22729851 | 0.84 | KDM4E (0.39) | KDM4EALDH1A1HSD17B10HPGDMAPK1 | |
| SCHEMBL22729413 | 0.83 | GRIN2B (0.35) | KDM4EALDH1A1MAPK1ALOX15TP53 | |
| SCHEMBL29839289 | 0.83 | GRIN2B (0.35) | KDM4EALDH1A1MAPK1ALOX15TP53 | |
| SCHEMBL22729672 | 0.83 | MGLL (0.32) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL22729439 | 0.82 | KDM4E (0.35) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL29839348 | 0.82 | KDM4E (0.35) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL22729718 | 0.82 | ALDH1A1 (0.39) | SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11459325-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11459325-B2 | Heterocyclic compound | GBA1, GBA2, GALC | SMN1; SMN2 155/4885KDM4E 1270/4885ALDH1A1 2660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.